亚太地区制药流体处理市场预测至 2028 年 – COVID-19 影响和区域分析 – 按产品(设备和解决方案及服务)、管道(TPE、PVC 和硅胶)、应用(流体处理和管理、流体制备、集成和自动化、无菌处理、缓冲液管理等)、用途 [止咳糖浆、静脉注射产品、复杂活性药物成分 (API) 等] 和最终用户(生物技术公司、制药和医疗公司等)其他)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 202    |    Report Code: BMIRE00028027    |    Category: Life Sciences

Asia-Pacific Pharmaceutical Fluid Handling Market

亚太制药流体处理市场预计将从 2022 年的 206041 万美元增长到 2028 年的 279215 万美元;预计 2022 年至 2028 年复合年增长率为 5.2%。

 

自动化流体处理系统借助机器学习在未来几年推动亚太制药流体处理市场

 

流体处理系统对于准备工作至关重要、移动和储存生物技术或制药厂的制造和卫生所需的液体。制药或生物技术制造工厂中的自动化流体处理系统将简化流程并提高其准确性。自动化流程减少了程序错误,从而减少了拒绝批次的情况。此外,自动化处理将直接清洁流体处理系统和制造单元,无需为清洁过程进行特殊准备。除了通过人工智能控制自动液体处理的各个阶段并利用互联网连接与处理程序远程交互之外,人工智能在自动化液体处理中的应用为市场增长提供了利润丰厚的机会。机器学习将使软件能够提供高水平的错误控制并使仪器适应新情况,例如对一次性吸头的缺陷做出反应或在使用机器学习处理样品时补偿堵塞的喷嘴。此外,新产品的推出促进了市场增长。因此,在预测期内,使用与机器学习集成的自动化流体处理系统可能会推动亚太地区制药流体处理市场的发展。

 

亚太制药流体处理市场概览

 

亚太制药流体处理市场是细分为中国、日本、印度、澳大利亚、韩国和亚太其他地区。亚太地区制药流体处理市场的增长归因于制药行业的发展、药品生产/制造的增长以及制药新药生产研发投资的增加。中国是最大的医药中间体和原料药生产国和出口国。该国向化学品和医药行业出口大量原料药和中间体。印度等亚太国家的制药行业。此外,该国拥有大量的国内药品制造部门和能力。政府还大力投资发展特殊工业区,以低成本进行基础设施开发和生产。

 

亚洲-太平洋制药流体处理市场收入及预测至 2028 年(百万美元)

 

< strong>亚太制药流体处理市场细分

 

亚太制药流体处理市场细分为:管道、应用、用途、最终用户和国家/地区。根据产品种类,亚太市场分为设备和设备。解决方案和服务。设备细分市场将在 2022 年获得更大的市场份额。

 

以管材为基础,亚太制药流体处理市场细分为 TPE 、PVC 和硅。硅细分市场在 2022 年占据最大的市场份额。

 

根据应用,亚太制药流体处理市场分为流体处理和管理、流体制备、集成和自动化、无菌处理、缓冲液管理等。流体处理和管理领域在 2022 年占据最大的市场份额。

 

根据使用情况,亚太制药流体处理市场细分为止咳糖浆、静脉注射产品、复杂活性药物成分 (API) 等。静脉注射产品细分市场在 2022 年占据最大市场份额。

 

根据最终用户,亚太制药流体处理市场细分进入生物技术公司、制药和医疗公司等。生物技术公司细分市场在 2022 年占据最大市场份额。

 

根据国家/地区,亚太制药流体处理市场细分为日本、中国、印度、韩国、澳大利亚和亚太其他地区。 2022 年中国市场份额最大。

 

Australian Fluid Handling Pty Ltd、CIRCOR International Inc、Danaher Corp、Merck KGaA、Parker Hannifin Corp、RAUMEDIC AG、Rochling SE 和Co KG、Spirax Sarco Engineering plc 和 Tef Cap Industries Inc 是亚太制药流体处理市场的领先公司。



Asia-Pacific Pharmaceutical Fluid Handling Strategic Insights

Strategic insights for Asia-Pacific Pharmaceutical Fluid Handling involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-pharmaceutical-fluid-handling-market-strategic-framework.webp
Get more information on this report

Asia-Pacific Pharmaceutical Fluid Handling Report Scope

Report Attribute Details
Market size in 2022 US$ 2,060.41 Million
Market Size by 2028 US$ 2,792.15 Million
Global CAGR (2022 - 2028) 5.2%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 产品
  • 设备
  • 解决方案和服务
By 管材
  • TPE
  • PVC
  • 硅胶
By 应用
  • 流体处理和管理
  • 流体制备
  • 集成和自动化
  • 无菌处理
  • 缓冲液管理
By 用途
  • 止咳糖浆
  • 静脉注射产品
  • 复合活性药物成分
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Australian Fluid Handling Pty Ltd
  • CIRCOR International Inc
  • Danaher Corp
  • Merck KGaA
  • Parker Hannifin Corp
  • RAUMEDIC AG
  • Rochling SE & Co KG
  • Spirax Sarco Engineering plc
  • Tef Cap Industries Inc
  • Get more information on this report

    Asia-Pacific Pharmaceutical Fluid Handling Regional Insights

    The regional scope of Asia-Pacific Pharmaceutical Fluid Handling refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-pharmaceutical-fluid-handling-market-geography.webp
    Get more information on this report

    The List of Companies - Asia-Pacific Pharmaceutical Fluid Handling Market

    1. Australian Fluid Handling Pty Ltd
    2. CIRCOR International Inc
    3. Danaher Corp
    4. Merck KGaA
    5. Parker Hannifin Corp
    6. RAUMEDIC AG
    7. Rochling SE & Co KG
    8. Spirax Sarco Engineering plc
    9. Tef Cap Industries Inc
    Frequently Asked Questions
    How big is the Asia-Pacific Pharmaceutical Fluid Handling Market?

    The Asia-Pacific Pharmaceutical Fluid Handling Market is valued at US$ 2,060.41 Million in 2022, it is projected to reach US$ 2,792.15 Million by 2028.

    What is the CAGR for Asia-Pacific Pharmaceutical Fluid Handling Market by (2022 - 2028)?

    As per our report Asia-Pacific Pharmaceutical Fluid Handling Market, the market size is valued at US$ 2,060.41 Million in 2022, projecting it to reach US$ 2,792.15 Million by 2028. This translates to a CAGR of approximately 5.2% during the forecast period.

    What segments are covered in this report?

    The Asia-Pacific Pharmaceutical Fluid Handling Market report typically cover these key segments-

  • 产品 (设备, 解决方案和服务)
  • 管材 (TPE, PVC, 硅胶)
  • 应用 (流体处理和管理, 流体制备, 集成和自动化, 无菌处理, 缓冲液管理)
  • What is the historic period, base year, and forecast period taken for Asia-Pacific Pharmaceutical Fluid Handling Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia-Pacific Pharmaceutical Fluid Handling Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Asia-Pacific Pharmaceutical Fluid Handling Market?

    The Asia-Pacific Pharmaceutical Fluid Handling Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Australian Fluid Handling Pty Ltd
  • CIRCOR International Inc
  • Danaher Corp
  • Merck KGaA
  • Parker Hannifin Corp
  • RAUMEDIC AG
  • Rochling SE & Co KG
  • Spirax Sarco Engineering plc
  • Tef Cap Industries Inc
  • Who should buy this report?

    The Asia-Pacific Pharmaceutical Fluid Handling Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia-Pacific Pharmaceutical Fluid Handling Market value chain can benefit from the information contained in a comprehensive market report.